Downloads: 202 | Views: 214
Research Paper | Medical Science | Indonesia | Volume 9 Issue 12, December 2020
Postpartum Rat Systolic Blood Pressure with Gynura Procumbens Leaf Extract
Erna Yovi Kurniawati | Mariza Mustika Dewi
Abstract: Introduction: Complications of postpartum hypertension can lead to retinal failure, kidney failure, stroke, pulmonary edema, damage to blood vessels in the heart, cerebrovascular sequela to cause death. The purpose of this study was to find out the picture of blood pressure of Wistar mice after the administration of Gynura procumbens extract. Material and Methode: This is a randomized controlled trial. The study subjects consisted of 20 female Wistar mice after giving birth which was divided into control groups and treatment groups. Induction of hypertension with a diet high in salt (NaCl 8 %, 3ml/hr) and prednisone 3 gr/kgBB was given for 14 days. Negative control group intervention using aquades 3ml/hr, positive control group intervention using nifedipine 3 mg/kg bb, and intervention group using Gynura procumbens extract 10 mg/kg bb and nifedipine 3 mg/kg bb. Intervention is carried out for 14 days. Result: The results showed that there was a significant increase in systolic blood pressure after the induction of hypertension and there was a greater decrease in systolic blood pressure values after intervention in the intervention group when compared to the positive control group, namely systolic blood pressure. Conclusion: decreased systolic blood pressure after administration of Gynura procumbens and nifedipine was greater than that given nifedipine alone. Gynura procumbens can lower systolic blood pressure values in postpartum Wistar mice.
Keywords: gynura procumbens, hypertension, postpartum
Edition: Volume 9 Issue 12, December 2020,
Pages: 4 - 6
Similar Articles with Keyword 'hypertension'
Research Paper, Medical Science, India, Volume 10 Issue 6, June 2021Pages: 563 - 564
Liddle it's A Riddle
Research Paper, Medical Science, India, Volume 11 Issue 8, August 2022Pages: 279 - 281
Formulation and Characterization of Macitantan Nanoparticles for the Treatment of Pulmonary Hypertension